Screening and identification of lncRNAs as potential biomarkers for pulmonary tuberculosis. 2017

Zhong-Liang Chen, and Li-Liang Wei, and Li-Ying Shi, and Meng Li, and Ting-Ting Jiang, and Jing Chen, and Chang-Ming Liu, and Su Yang, and Hui-Hui Tu, and Yu-Ting Hu, and Lin Gan, and Lian-Gen Mao, and Chong Wang, and Ji-Cheng Li
Institute of Cell Biology, Zhejiang University, Hangzhou, 310058, P.R. China.

Pulmonary tuberculosis (TB) is among the diseases with the highest morbidity and mortality worldwide. Effective diagnostic methods for TB are lacking. In this study, we investigated long non-coding RNAs (lncRNAs) in plasma using microarray and the potential diagnostic value of lncRNAs for TB. We found a total of 163 up-regulated lncRNAs and 348 down-regulated lncRNAs. Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and coding-noncoding co-expression (CNC) analyses showed that functions of differentially expressed lncRNAs were mainly enriched in the regulation of alpha-beta T cell activation and the T cell receptor signalling pathway. Four differentially expressed lncRNAs, NR_038221 (fold change = 3.79, P < 0.01), NR_003142 (fold change = 1.69, P < 0.05), ENST00000570366 (fold change = 3.04, P < 0.05), and ENST00000422183 (fold change = 2.11, P < 0.001), were verified using RT-qPCR. Among those, NR_038221, NR_003142, and ENST00000570366 were found to be up-regulated, while ENST00000422183 was down-regulated. The value of the area under the curve (AUC) for the diagnostic model consisting of the four lncRNAs was 0.845 (sensitivity = 79.2%, specificity = 75%). We further predicted 85 mRNAs and 404 miRNAs that potentially interact with these lncRNAs. Our study revealed the potential value of lncRNAs as biomarkers for early diagnosis of TB and the underlying mechanisms of these abnormally expressed lncRNAs in the pathogenesis of TB.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012372 ROC Curve A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli. ROC Analysis,Receiver Operating Characteristic,Analysis, ROC,Analyses, ROC,Characteristic, Receiver Operating,Characteristics, Receiver Operating,Curve, ROC,Curves, ROC,ROC Analyses,ROC Curves,Receiver Operating Characteristics
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

Zhong-Liang Chen, and Li-Liang Wei, and Li-Ying Shi, and Meng Li, and Ting-Ting Jiang, and Jing Chen, and Chang-Ming Liu, and Su Yang, and Hui-Hui Tu, and Yu-Ting Hu, and Lin Gan, and Lian-Gen Mao, and Chong Wang, and Ji-Cheng Li
May 2021, Tuberculosis (Edinburgh, Scotland),
Zhong-Liang Chen, and Li-Liang Wei, and Li-Ying Shi, and Meng Li, and Ting-Ting Jiang, and Jing Chen, and Chang-Ming Liu, and Su Yang, and Hui-Hui Tu, and Yu-Ting Hu, and Lin Gan, and Lian-Gen Mao, and Chong Wang, and Ji-Cheng Li
January 2018, Tuberculosis (Edinburgh, Scotland),
Zhong-Liang Chen, and Li-Liang Wei, and Li-Ying Shi, and Meng Li, and Ting-Ting Jiang, and Jing Chen, and Chang-Ming Liu, and Su Yang, and Hui-Hui Tu, and Yu-Ting Hu, and Lin Gan, and Lian-Gen Mao, and Chong Wang, and Ji-Cheng Li
February 2022, Clinical breast cancer,
Zhong-Liang Chen, and Li-Liang Wei, and Li-Ying Shi, and Meng Li, and Ting-Ting Jiang, and Jing Chen, and Chang-Ming Liu, and Su Yang, and Hui-Hui Tu, and Yu-Ting Hu, and Lin Gan, and Lian-Gen Mao, and Chong Wang, and Ji-Cheng Li
January 2020, BioMed research international,
Zhong-Liang Chen, and Li-Liang Wei, and Li-Ying Shi, and Meng Li, and Ting-Ting Jiang, and Jing Chen, and Chang-Ming Liu, and Su Yang, and Hui-Hui Tu, and Yu-Ting Hu, and Lin Gan, and Lian-Gen Mao, and Chong Wang, and Ji-Cheng Li
January 2022, Journal of oncology,
Zhong-Liang Chen, and Li-Liang Wei, and Li-Ying Shi, and Meng Li, and Ting-Ting Jiang, and Jing Chen, and Chang-Ming Liu, and Su Yang, and Hui-Hui Tu, and Yu-Ting Hu, and Lin Gan, and Lian-Gen Mao, and Chong Wang, and Ji-Cheng Li
May 2024, International immunopharmacology,
Zhong-Liang Chen, and Li-Liang Wei, and Li-Ying Shi, and Meng Li, and Ting-Ting Jiang, and Jing Chen, and Chang-Ming Liu, and Su Yang, and Hui-Hui Tu, and Yu-Ting Hu, and Lin Gan, and Lian-Gen Mao, and Chong Wang, and Ji-Cheng Li
October 2018, Cancer genetics,
Zhong-Liang Chen, and Li-Liang Wei, and Li-Ying Shi, and Meng Li, and Ting-Ting Jiang, and Jing Chen, and Chang-Ming Liu, and Su Yang, and Hui-Hui Tu, and Yu-Ting Hu, and Lin Gan, and Lian-Gen Mao, and Chong Wang, and Ji-Cheng Li
January 2021, Frontiers in pharmacology,
Zhong-Liang Chen, and Li-Liang Wei, and Li-Ying Shi, and Meng Li, and Ting-Ting Jiang, and Jing Chen, and Chang-Ming Liu, and Su Yang, and Hui-Hui Tu, and Yu-Ting Hu, and Lin Gan, and Lian-Gen Mao, and Chong Wang, and Ji-Cheng Li
January 2021, International journal of endocrinology,
Zhong-Liang Chen, and Li-Liang Wei, and Li-Ying Shi, and Meng Li, and Ting-Ting Jiang, and Jing Chen, and Chang-Ming Liu, and Su Yang, and Hui-Hui Tu, and Yu-Ting Hu, and Lin Gan, and Lian-Gen Mao, and Chong Wang, and Ji-Cheng Li
January 2022, Journal of oncology,
Copied contents to your clipboard!